Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph El Youssef

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
The Lancet. Diabetes & Endocrinology|September 20, 2016
IN CONTROL of type 1 diabetes, despite hypoglycaemia unawarenessJoseph El Youssef
Diabetes Technology & Therapeutics|May 12, 2015
Treatment challenges for the young patient with type 1 diabetesJoseph El Youssef, W Kenneth Ward
Journal of Diabetes Science and Technology|January 10, 2012
Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemiaW Kenneth Ward, Jessica R Castle, Joseph El Youssef
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 23, 2017
Design of a dual-hormone model predictive control for artificial pancreas with exercise modelNavid Resalat, Joseph El Youssef, Ravi Reddy, et al.
Plos One|July 26, 2019
A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise modelNavid Resalat, Joseph El Youssef, Nichole Tyler, et al.
Journal of Diabetes Science and Technology|December 7, 2010
Factors influencing the effectiveness of glucagon for preventing hypoglycemiaJessica R Castle, Julia M Engle, Joseph El Youssef, et al.
Clinical Drug Investigation|May 10, 2012
Discomfort from an alkaline formulation delivered subcutaneously in humans: albumin at pH 7 versus pH 10W Kenneth Ward, Jessica R Castle, Deborah L Branigan, et al.
Diabetes Technology & Therapeutics|October 1, 2010
Continuous glucose monitoring in subjects with type 1 diabetes: improvement in accuracy by correcting for background currentJoseph El Youssef, Jessica R Castle, Julia M Engle, et al.
IEEE Journal of Biomedical and Health Informatics|July 23, 2016
Modeling Glucagon Action in Patients With Type 1 DiabetesA Emami, Joseph El Youssef, Remi Rabasa-Lhoret, et al.
Journal of Diabetes Science and Technology|October 10, 2019
Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control InputsNavid Resalat, Wade Hilts, Joseph El Youssef, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The Lancet. Diabetes & Endocrinology|September 20, 2016
IN CONTROL of type 1 diabetes, despite hypoglycaemia unawarenessJoseph El Youssef
Diabetes Technology & Therapeutics|May 12, 2015
Treatment challenges for the young patient with type 1 diabetesJoseph El Youssef, W Kenneth Ward
Journal of Diabetes Science and Technology|January 10, 2012
Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemiaW Kenneth Ward, Jessica R Castle, Joseph El Youssef
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 23, 2017
Design of a dual-hormone model predictive control for artificial pancreas with exercise modelNavid Resalat, Joseph El Youssef, Ravi Reddy, et al.
Plos One|July 26, 2019
A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise modelNavid Resalat, Joseph El Youssef, Nichole Tyler, et al.
Journal of Diabetes Science and Technology|December 7, 2010
Factors influencing the effectiveness of glucagon for preventing hypoglycemiaJessica R Castle, Julia M Engle, Joseph El Youssef, et al.
Clinical Drug Investigation|May 10, 2012
Discomfort from an alkaline formulation delivered subcutaneously in humans: albumin at pH 7 versus pH 10W Kenneth Ward, Jessica R Castle, Deborah L Branigan, et al.
Diabetes Technology & Therapeutics|October 1, 2010
Continuous glucose monitoring in subjects with type 1 diabetes: improvement in accuracy by correcting for background currentJoseph El Youssef, Jessica R Castle, Julia M Engle, et al.
IEEE Journal of Biomedical and Health Informatics|July 23, 2016
Modeling Glucagon Action in Patients With Type 1 DiabetesA Emami, Joseph El Youssef, Remi Rabasa-Lhoret, et al.
Journal of Diabetes Science and Technology|October 10, 2019
Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control InputsNavid Resalat, Wade Hilts, Joseph El Youssef, et al.
Pageof 4